ARCHIVES

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

This article is from The Cancer Letter archive.

Vol. 34 No. 36 | October 3, 2008

Download PDF Visit The Full Archive

Related Articles

Payline For 1988 Would Be Around 160 With President’s Budget

January 16, 1987

Phase III Study: Lymphoseek Superior to Vital Blue Dye

June 24, 2011

Cancer Survival Now May Be Well Over 50 Percent, ACS President Says; Cigarette Consumption Drops

April 6, 1984

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

Voluntary Organizations: ACS Board Approves Prostate Cancer Funding Set-Asides

November 15, 1996

In Brief: 896 Nurses Pass Oncology Certification Exam; ACS Awards 375 New Grants Worth $43.8 Million

July 6, 1990